Related Experiment Videos
Adenosine analogs and sleep in rats
The Journal of Pharmacology and Experimental Therapeutics
|February 1, 1984
Summary
Adenosine analogs like N6-L-(phenylisopropyl)adenosine significantly increased slow-wave sleep in rats at nanomolar doses. Higher micromolar doses diminished these sleep-promoting effects, suggesting A1 receptor activation.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Adenosine plays a crucial role in regulating sleep-wake cycles.
- Adenosine receptors (A1 and A2) are implicated in modulating sleep architecture.
Purpose of the Study:
- To investigate the dose-dependent effects of specific adenosine analogs on sleep in rats.
- To determine the receptor subtype (A1 vs. A2) responsible for the observed sleep alterations.
Main Methods:
- Administration of N6-L-(phenylisopropyl)adenosine, cyclohexyladenosine, and adenosine-5'-N-ethylcarboxamide to rats.
- Monitoring and quantifying changes in sleep stages, including slow-wave sleep and rapid-eye-movement sleep.
- Evaluating dose-response relationships from nanomolar to micromolar concentrations.
Main Results:
- Increased slow-wave sleep (SWS) and rapid-eye-movement sleep (REM) were observed at lower doses (nanomolar to low micromolar) of the adenosine analogs.
- Higher doses (0.9 mumol/kg) led to decreased REM sleep and varied effects on wakefulness and total sleep.
- The efficacy of sleep promotion diminished significantly at higher drug concentrations.
Conclusions:
- Adenosine analogs exert significant effects on sleep architecture, particularly SWS and REM sleep.
- The sleep-promoting effects are dose-dependent, with optimal activity in the nanomolar range.
- Findings suggest that A1 receptor activation, which occurs at lower concentrations, is primarily responsible for the observed sleep effects, rather than A2 receptor activation requiring higher concentrations.